Anxiety Is Associated With Uninvestigated and Functional Dyspepsia (Rome III Criteria) in a Swedish Population-Based Study
Background & Aims
The Rome III criteria for functional dyspepsia have been changed to include 2 distinct syndromes: postprandial distress syndrome and epigastric pain syndrome. We investigated risk factors for functional dyspepsia among the functional dyspepsia subgroups defined by the Rome III criteria.
Methods
We performed a cross-sectional population-based study in a primary care setting (the Kalixanda study). A random sample (n = 2860) of the adult population from 2 northern Swedish municipalities (n = 21,610) was surveyed using a validated postal questionnaire to assess gastrointestinal symptoms (response rate, 74.2%; n = 2122). A randomly selected subgroup (n = 1001) of responders was invited to undergo an esophagogastroduodenoscopy (participation rate, 73.3%) including biopsy specimen collection, Helicobacter pylori culture and serology, and symptom assessments.
Results
Of the 1001 subjects examined by endoscopy, 202 (20.2%; 95% confidence interval [CI], 17.7–22.7) were classified as having uninvestigated dyspepsia and 157 (15.7%; 95% CI, 13.4–18.0) as having functional dyspepsia. Major anxiety (Hospital Anxiety and Depression Scale score ≥11) was associated with uninvestigated dyspepsia (odds ratio [OR], 3.01; 95% CI, 1.39–6.54), as was obesity (body mass index ≥30 kg/m2) (OR, 1.86; 95% CI, 1.15–3.01). Major anxiety was associated with functional dyspepsia and postprandial distress syndrome (OR of 2.56 [95% CI, 1.06–6.19] and 4.35 [95% CI, 1.81–10.46], respectively), as was use of nonsteroidal anti-inflammatory drugs (OR, 2.49 [95% CI, 1.29–4.78] and 2.75 [95% CI, 1.38–5.50], respectively). Depression was not associated with any dyspepsia group.
Conclusions
Anxiety but not depression is linked to uninvestigated dyspepsia, functional dyspepsia, and postprandial distress syndrome but not to epigastric pain syndrome.
Abbreviations used in this paper: CI, confidence interval, HADS, Hospital Anxiety and Depression Scale, OR, odds ratio
Conflicts of interest The authors disclose the following: E.B.-S. is an employee of AstraZeneca. The remaining authors disclose no conflicts.
Funding Supported in part by the Swedish Research Council, the Swedish Society of Medicine (Stockholm, Sweden), Mag-Tarm Sjukas Förbund (Stockholm, Sweden), the Norrbotten County Council, Sweden, and AstraZeneca R&D (Mölndal, Sweden). The study sponsors had no role in the study design or in the collection, analysis, and interpretation of data.
PII: S0016-5085(09)00467-3
doi:10.1053/j.gastro.2009.03.039
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
- New Epidemiologic Evidence on Functional Dyspepsia Subgroups and Their Relationship to Psychosocial Dysfunction , 01 June 2009


